It is not mandatory if you feel fine, but it is a reasonable preventive measure, especially during dose increases when new symptoms can emerge
MASH affects approximately 6 to 8 million people in the United States
Struggling with weight management can affect nearly every aspect of daily life
88141 Cytopathology, cervical or vaginal smear (Papanicolaou smear), requiring interpretation by physician
In the years since Ozempic came to market, GLP-1 drugs have catapulted to stardom, becoming a multibillion-dollar industry with a surreal series of successes, first as an effective treatment for diabetes and then as a hit for weight loss
A product prescribed against a non-weight indication cardiovascular risk reduction, obstructive sleep apnea, MASH, or type 2 diabetes is assessed on that indication rather than as a weight-loss agent